Progress in Development of Liver Fluke Vaccines
Parasitology Today, ISSN: 0169-4758, Vol: 14, Issue: 6, Page: 224-228
1998
- 135Citations
- 75Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations135
- Citation Indexes134
- 134
- CrossRef113
- Policy Citations1
- Policy Citation1
- Captures75
- Readers75
- 75
Review Description
Infection of ruminants by Fasciola spp continues to cause large economic losses worldwide. Recent results from several laboratories have demonstrated that animals can be significantly protected against infection by vaccination with defined Fasciola antigens. Apart from reducing fluke burdens, some vaccines can elicit a concurrent reduction in parasite egg production. The expectation of a commercially feasible vaccine that might also reduce parasite transmission in the field is now realistic, although major hurdles still exist. Here, Terry Spithill and John Dalton review the results of several recent vaccine trials and discuss the future prospects for vaccine development.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0169475898012459; http://dx.doi.org/10.1016/s0169-4758(98)01245-9; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0031814263&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/17040765; https://linkinghub.elsevier.com/retrieve/pii/S0169475898012459; http://linkinghub.elsevier.com/retrieve/pii/S0169475898012459; http://api.elsevier.com/content/article/PII:S0169475898012459?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0169475898012459?httpAccept=text/plain; http://dx.doi.org/10.1016/s0169-4758%2898%2901245-9; https://dx.doi.org/10.1016/s0169-4758%2898%2901245-9
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know